91.5%, respectively; P = 0.077); this difference approached but did not reach statistical significance.
← all excerpts
A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore<sup>™</sup>) with the 22-gauge needle in patients with solid pancreatic mass lesions.
1
—
—